Literature DB >> 17604869

Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.

Christopher L Washenberger1, Jian-Qiu Han, Katherina J Kechris, Babal Kant Jha, Robert H Silverman, David J Barton.   

Abstract

Ribonuclease L (RNase L) is an antiviral endoribonuclease that cleaves hepatitis C virus (HCV) RNA at single-stranded UA and UU dinucleotides throughout the open reading frame (ORF). To determine whether RNase L exerts evolutionary pressure on HCV we examined the frequencies of UA and UU dinucleotides in 162 RNA sequences from the Los Alamos National Labs HCV Database (http://hcv.lanl.gov). Considering the base composition of the HCV ORFs, both UA and UU dinucleotides were less frequent than predicted in each of 162 HCV RNAs. UA dinucleotides were significantly less frequent than predicted at each of the three codon positions while UU dinucleotides were less frequent than predicted predominantly at the wobble position of codons. UA and UU dinucleotides were among the least abundant dinucleotides in HCV RNA ORFs. Furthermore, HCV genotype 1 RNAs have a lower frequency of UA and UU dinucleotides than genotype 2 and 3 RNAs, perhaps contributing to increased resistance of HCV genotype 1 infections to interferon therapy. In vitro, RNase L cleaved both HCV genotype 1 and 2 RNAs efficiently. Thus, RNase L can cleave HCV RNAs efficiently and variably reduced frequencies of UA and UU dinucleotides in HCV RNA ORFs are consistent with the selective pressure of RNase L.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604869      PMCID: PMC2186174          DOI: 10.1016/j.virusres.2007.05.020

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  65 in total

1.  Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.

Authors:  L Rusch; B Dong; R H Silverman
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

Review 2.  Retention and repression: fates of hyperedited RNAs in the nucleus.

Authors:  Joshua DeCerbo; Gordon G Carmichael
Journal:  Curr Opin Cell Biol       Date:  2005-06       Impact factor: 8.382

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

5.  Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.

Authors:  Nicole Pavio; Deborah R Taylor; Michael M C Lai
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Authors:  Gary L Davis; John B Wong; John G McHutchison; Michael P Manns; Joann Harvey; Janice Albrecht
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

7.  Tissue-specific codon usage and the expression of human genes.

Authors:  Joshua B Plotkin; Harlan Robins; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

Review 9.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

Review 10.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

View more
  35 in total

Review 1.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

2.  Recognition of 2',5'-linked oligoadenylates by human ribonuclease L: molecular dynamics study.

Authors:  Kamil Maláč; Ivan Barvík
Journal:  J Mol Model       Date:  2014-03-16       Impact factor: 1.810

3.  Integrative RNA-seq and microarray data analysis reveals GC content and gene length biases in the psoriasis transcriptome.

Authors:  William R Swindell; Xianying Xing; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Physiol Genomics       Date:  2014-05-20       Impact factor: 3.107

4.  Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.

Authors:  Cara C Burns; Ray Campagnoli; Jing Shaw; Annelet Vincent; Jaume Jorba; Olen Kew
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

5.  Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

Authors:  Maureen J Donlin; Nathan A Cannon; Rajeev Aurora; Jia Li; Abdus S Wahed; Adrian M Di Bisceglie; John E Tavis
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

6.  Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response.

Authors:  Yuchen Han; Jesse Donovan; Sneha Rath; Gena Whitney; Alisha Chitrakar; Alexei Korennykh
Journal:  Science       Date:  2014-02-27       Impact factor: 47.728

Review 7.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

Review 8.  Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

9.  A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L.

Authors:  Hannah L Townsend; Babal K Jha; Robert H Silverman; David J Barton
Journal:  RNA Biol       Date:  2008-10-09       Impact factor: 4.652

10.  Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts.

Authors:  Francisco P Lobo; Bruno E F Mota; Sérgio D J Pena; Vasco Azevedo; Andréa M Macedo; Andreas Tauch; Carlos R Machado; Glória R Franco
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.